Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.830
+0.060 (3.39%)
At close: Feb 6, 2026, 4:00 PM EST
1.821
-0.009 (-0.49%)
After-hours: Feb 6, 2026, 7:59 PM EST

Dermata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
432514-
Market Cap Growth
-7.70%27.62%-56.38%-65.85%--
Enterprise Value
-0-3-4-32-
Last Close Price
1.8313.5091.50981.604176.00-
PB Ratio
0.391.770.340.821.43-
P/TBV Ratio
1.101.770.340.821.43-
Debt / Equity Ratio
------1.12
Quick Ratio
4.201.604.586.787.120.14
Current Ratio
4.561.794.917.537.660.16
Return on Equity (ROE)
-203.36%-310.44%-125.96%-119.18%-228.09%-
Return on Assets (ROA)
-96.45%-135.86%-67.36%-65.13%-80.31%-148.47%
Return on Capital Employed (ROCE)
-229.10%-801.60%-126.50%-160.70%-77.70%99.80%
Earnings Yield
-202.58%-446.00%-361.07%-194.19%-54.53%-
Buyback Yield / Dilution
-871.92%-684.78%----
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q